Key Finding
Artemisinin and its derivatives demonstrate significant immunomodulatory effects through multiple pathways including NF-κB inhibition, effectively suppressing pathogenic immune responses in autoimmune and inflammatory diseases with low toxicity profiles.
Researchers have discovered that artemisinin, a natural compound derived from sweet wormwood (an herb used in traditional Chinese medicine), may offer new hope for treating autoimmune and inflammatory conditions. While artemisinin has long been recognized as a malaria treatment, this comprehensive review examines how it and its synthetic derivatives work to calm overactive immune systems in conditions like rheumatoid arthritis and other autoimmune disorders.
The study found that artemisinin compounds work through multiple pathways in the body to reduce inflammation and regulate immune responses. They suppress harmful immune cells that attack the body's own tissues, reduce antibody production, and promote regulatory cells that help maintain immune balance. Importantly, newer synthetic versions show low toxicity and good absorption, making them potentially safer than some current treatments.
The mechanisms involve blocking inflammatory signals through pathways like NF-κB, TNF, and IL-6, which are well-known targets in inflammatory disease. By interrupting these signals, artemisinin can reduce joint inflammation, protect organs from autoimmune damage, and decrease overall disease activity. Clinical trials are currently underway to test these compounds in patients with rheumatic and autoimmune conditions.
For patients considering acupuncture, this research is particularly relevant because artemisinin comes from traditional Chinese herbal medicine, suggesting potential synergies between herbal therapy and acupuncture for autoimmune conditions. Both approaches aim to restore balance and regulate immune function through complementary mechanisms. If you're interested in exploring acupuncture or herbal medicine for autoimmune conditions, seek a licensed acupuncturist with specialized training in traditional Chinese medicine and autoimmune disorders.
This comprehensive review examines artemisinin and its derivatives (artesunate, dihydroartemisinin, artemether, SM735, SM905, SM934) as immunomodulatory agents for rheumatic skeletal disorders and autoimmune diseases. The compounds demonstrate immunosuppressive effects through inhibition of pathogenic T cell activation, suppression of B cell function and antibody production, and enhanced regulatory T cell differentiation. Mechanistic pathways include TNF, TLR, IL-6, RANKL, MAPK, PI3K/AKT/mTOR, JAK/STAT, and NRF2/GPX4 modulation. Notably, artemisinin disrupts NF-κB signaling through upstream cascade interference and direct NF-κB binding, downregulating inflammatory chemokines and receptors that govern immune cell function, apoptosis, proliferation, and antioxidant responses. This results in therapeutic effects on systemic autoimmune diseases and organ-specific autoimmune manifestations affecting kidneys, nervous system, skin, liver, and biliary tract. Newer synthetic derivatives offer improved bioavailability and reduced toxicity profiles. Multicenter randomized clinical trials are ongoing to translate preclinical efficacy into clinical applications for rheumatic, inflammatory, and autoimmune conditions.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 QSYQ formula improved heart failure outcomes in mice by restoring myocardial energy metabolism through AMPK pathway activation, increasing ATP production while reducing oxidative stress and improving cardiac function.
📌 Chinese herbal medicine use in chronic kidney disease patients was associated with a 23-31% reduction in risk of major adverse cardiac events and all-cause mortality over a 17-year follow-up period.
📌 Six food and medicine homology plants demonstrate multi-target therapeutic mechanisms in coronary heart disease through immunomodulation, particularly affecting CD4+ memory activated T cells and naïve B cells, with four hub genes showing validated causal associations with CHD.